ARCHIVES

BMS Demands Resignation Of Two ImClone Executives

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988

BSA Strikes Down NCI Tissue Bank Plan, Calls for Audit of caBIG

March 11, 2011

Sharfstein To Leave FDA

January 7, 2011

Thompson Tours Brown’s Brain Science Center.

March 16, 2001

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005